Home Amgen, Cytokinetics Heart Failure Drug Succeeds In Mid-Stage Study
 

Keywords :   


Amgen, Cytokinetics Heart Failure Drug Succeeds In Mid-Stage Study

2015-10-28 08:39:05| Biotech - Topix.net

Amgen Inc and Cytokinetics Inc said on Tuesday their experimental drug for chronic heart failure showed significant improvement in cardiac function in the second part of a mid-stage study. The 448 patients in the trial were given an oral formulation of the drug omecamtiv mecarbil for 20 weeks and observed for 24 weeks, the companies said in a joint statement.

Tags: study heart drug failure

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.09This Week in Agribusiness, September 28, 2024
28.09This Week in Agribusiness, September 28, 2024
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Weekly Recap: AkzoNobel, BASF, Axalta, PPG Top This Weeks Stories
28.09Post-Tropical Cyclone Helene Graphics
28.09Post-Tropical Cyclone Helene Public Advisory Number 20
28.09Hurricane Isaac Graphics
More »